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with corticosteroids. Aim of the study. To understand which macro-
phage subtypes express the folate receptor and can be visualized using
SPECT imaging and whether these macrophages are affected by treat-
ment with corticosteroids (Triamcinolone).
Methods: In vivo. In twenty 16-week-old male Wistar rats severe
osteoarthritis was induced using a low dose intra-articular papain
injections in their left knee joints combined with exposure to a
moderate exercise protocol. Animals were divided over two groups:
ten rats served as untreated OA controls and ten rats were treated
during the experiment with weekly intra-articular injections of tri-
amcinolone acetonide (100ug in 70ul saline). After six weeks an in vivo
folate SPECT/CT scan and ex vivo EPIC-mCT and histology was obtained.
In vitro. We generated macrophages from human peripheral blood
monocytes in vitro by culturing them for 7 days in the presence of GM-
CSF (M1 proinﬂammatory phenotype) or M-CSF (M2 anti-inﬂamma-
tory phenotype). Subsequently, we treated the macrophages with LPS,
cytokines (IL-4, IL-10, IFN-y) or triamcinolone acetonide (1ug/ml). FR-b
(FOLR2) and macrophage marker expression was measured using
FACS.
Results: . Increased macrophage activation was seen on SPECT-scans
in OA induced knees versus control knees. Interestingly, treatment
with corticosteroids resulted in reduced OA severity but an increase
in activated macrophages seen on folate-SPECT imaging (ﬁgure1). On
human in vitro generated macrophages Folate receptor expression
was high in M2 macrophages and very low in M1 macrophages. There
were only small differences between M2 macrophages stimulated
with IL-4 or IL-10 alone. But when M2 macrophages were stimulated
with IL-4 and IL-10 simultaneously, the number of positive cells and
the ﬂuorescent intensity increased approximately 1.5 - 2 fold com-
pared to unstimulated M2 macrophages (ﬁgure2). Triamcinolone
acetonide signiﬁcantly reduced TNF-a production by M1 macro-
phages but did not affect M1 or M2 surface markers or folate receptor
expression.
Conclusions: Our data indicate that the increase in macrophage acti-
vation as seen on SPECT is most likely due to an increase in M2 anti-
inﬂammatory macrophages. However, from these results we cannot
infer which M2 subtype is present in our animal model. It is known that
corticosteroids can inﬂuence macrophage subtypes but we were not
able to show these effects in vitro, although in-vitro stimulation with
IL4þIl10 induced a folate receptor positive subtype within the M2
population. Our study suggests that not all macrophage subtypes are
detrimental. Maintaining the balance between the various macrophage
subtypes may thus be the key to maintain healthy joint homeostasis
and prevent osteophytosis.Figure 1. Macrophage activation determined after injection of 111In-DTPA-
folate using SPECT/CT in Papaine induced osteoarthritis (OA) combined
with moderate excercise. Representative sagittal SPECT/CT images of knee
joints from representative animals per experimental group. CT images
shown in black and white were used for anatomical reference, the SPECT
images are shown in color. Patellar bone is shown with osteophyte for-
mation highlighted in red.Figure 2. Fluorescent intensity of FOLR2 staining on human macrophages
differentiated in vitro. Average results from two representative experi-
ment are shown.
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S100 PROTEINS INDUCE CANONICAL WNT SIGNALING, WHICH
CAUSES INCREASED EXPRESSION OF MMPS IN THE SYNOVIUM
M.H. van den Bosch, A.B. Blom, P. Hoek, R.F. Schelbergen,
W.B. van den Berg, P.M. van der Kraan, P.L. van Lent. Radboud Univ. Med.
Center, Nijmegen, Netherlands
Purpose: Many osteoarthritis (OA) patients show synovial activation,
which is thought to be involved in joint destruction. Previously, we
found that the alarmins S100A8 and A9, and various members of the
Wnt signaling pathway, including Wnt16, were highly increased in the
synovium of knee joints during experimental OA. WISP1, a downstream
protein of b-catenin-dependent canonical Wnt signaling, was increased
in both synovium and cartilage. S100A9 KO mice showed strongly
reduced pathology in experimental OA. Wnt signaling has been linked
to OA through activation of b-catenin, but the role of the synovium in
OA pathology under the inﬂuence of Wnt signaling is unclear. In this
study we investigated whether S100 proteins induce Wnt signaling and
determined the potency of Wnts to increase expression of cartilage-
degrading enzymes in the synovium.
Methods: Pathway analysis of microarray data from synovium of a
collagenase-induced OA was done using DAVID. Activation of Wnt sig-
naling was determined with b-catenin immunostaining of whole knee
joint sections. Gene expression was analyzed by qPCR. Human OA
synovial specimens were collected from joint replacement surgery and
stimulated with S100 or members of the Wnt signaling pathway or
blocked with the Wnt inhibitors FrzB and DKK-1.
Results: Pathway analysis showed enrichment of Wnt signaling in the
synovium during experimental OA. Because upregulation of both S100
andWnt proteins during experimental OA showed comparable kinetics,
we determined if S100 proteins could induce Wnt signaling. We found
that injections of S100A8 into mouse knee joints led to increased
expression of Wnt16 and WISP1 in the synovium and b-catenin accu-
mulation in the synovium and in the cartilage. Underlining an inter-
relationship between Wnt signaling and S100A8/9, we found less b-
catenin accumulation in both the synovium and cartilage during
experimental OA in S100A9 KOmice, suggesting a decrease in canonical
Wnt signaling. To determine the effects of canonical Wnt signaling in
the synovium, we overexpressed Wnt8a and Wnt16 in vivo in the
synoviumwith adenoviral vectors. This resulted in increased expression
of various MMPs in the synovium. To translate these ﬁndings to a
human situation, we stimulated human OA synovial tissues with
Wnt3a, as a model for a canonical Wnt, and WISP1. This led to sig-
niﬁcantly increased expression of MMP1, MMP9 and MMP13, whereas
the expression of the MMP inhibitors TIMP1 and 3 was not altered.
Next, we hypothesized that if Wnt signaling was increased in OA
synovium and that stimulation of synovium with members of the Wnt
Figure 1(A) A timeline over the study. (B) Scatter plots over individual
cytokine concentrations at ﬁrst (þ) and second (x) examinations with box
plots summarizing the examinations using the timeline as x-axis. Boxes
represent the median and quartiles, whiskers the 10th and 90th percen-
tiles, and the box widths the relative sample sizes at the two examina-
tions. Tables show median (25th and 75th percentiles) concentrations with
p-values from related-samples Wilcoxon signed-rank test from compar-
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A50signaling pathway led to increased expression of various MMPs, that we
should be able to decrease the expression of MMPs by blocking theWnt
signaling pathway. Immediate inhibition of Wnt signaling in human OA
synovium by addition of FrzB, a general Wnt inhibitor, or DKK-1,
selectively blocking canonical Wnt signaling, led to signiﬁcantly
decreased expression of MMP1, MMP3, MMP9 and MMP13. In contrast,
increased Wnt signaling did not result in an upregulation of S100
proteins.
Conclusions: S100 proteins are able to increase Wnt signaling. Can-
onical Wnts produced in the synovium may play an important role in
OA pathology. Stimulation of human OA synoviumwith Wnts increases
the expression of MMPs, whereas blockingWnt signaling in OA synovial
tissue results in decreased expression of MMPs. This underlines
increased Wnt signaling during OA to be a potential target for therapy.
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ASSOCIATION BETWEEN TISSUE-INFLAMMATION BIOMARKERS AND
PROGRESSION OF OSTEOARTHRITIS: EVIDENCE FROM THE
ROTTERDAM STUDY
F. Saberi Hosnijeh y, A. Siebuhr z, A. Uitterlinden y, A. Hofman y,
M. Karsdal z, S. Bierma-Zeinstra y, A. Bay-Jensen z, J. van Meurs y.
y Erasmus Med. Ctr., Rotterdam, Netherlands; zNordic BioSci., Herlev,
Denmark
Purpose: To investigate the prognostic value of matrix metal-
loproteinase (MMP)-dependent degradation of C reactive protein (CRP)
(CRPM) and connective tissue type I collagen turnover (C1M) on the
incidence and progression of radiographic osteoarthritis (OA) of the
knee and hip in the Rotterdam Study. Moreover, independent effect of
these biomarkers to the established biomarkers of OA progression, type
II collagen degradation (CTX-II) and serum cartilage oligomeric protein
(COMP), was evaluated.
Methods: Serum levels of C1M, CRPM, COMP and CRP of 1335 partic-
ipants aged >55 years were measured in fasting serum using ELISA. The
commercial ELISA detecting CTX-II was used in urine (uCTX-II). X-rays at
baseline and 5 years follow-upwere scored for radiographic OA stage by
Kellgren-Lawrence grade. The associations between OA and the bio-
markers were examined using logistic regression and generalized
estimating equations adjusted for age, sex, BMI, and possible other
confounders. Prediction value of the biomarkers was evaluated com-
pared with demographic characteristics and joint pain.
Results: The uCTX-II and COMP concentrations were associated with
the prevalence, incidence, and progression of OA. C1M, CRPM and CRP
were not associated with prevalence of OA. However, higher levels of
CRP were associated with incidence risk of knee and hip OA. Moreover,
OA progression was positively associated with CRPM (OR¼1.2, 95%
CI¼1-1.5, p¼0.04) and CRP (OR¼1.3, 95%CI¼1-1.6, p¼0.03) levels
independent of uCTX-II and COMP.
Conclusions: Our study conﬁrmed the associations between uCTX-II
and COMP concentrations and hip OA and/or knee OA progression.
Moreover, we showed for the ﬁrst time that a MMP-dependent tissue-
inﬂammation marker predicts the risk of OA progression independent
of established biomarkers uCTX-II and COMP.
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INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR ALPHA IN
SYNOVIAL FLUID ARE ASSOCIATED WITH PROGRESSION OF
RADIOGRAPHIC OSTEOARTHRITIS IN SUBJECTS WITH PREVIOUS
MENISCECTOMY
S. Larsson y, M. Englund y,z, A. Struglics y, S. Lohmander y,x.
yOrthopaedics, Dept. of Clinical Sci. Lund, Lund Univ., Lund, Sweden;
zClinical Epidemiology Res. & Training Unit, Boston Univ. Sch. of Med.,
Boston, MA, United States; xRes. Unit for Musculoskeletal Function and
Physiotherapy and Dept. of Orthopaedics and Traumatology, Univ. of
Southern Denmark, Odense, Denmark
Purpose: To investigate in an exploratory study whether synovial ﬂuid
concentrations of pro-inﬂammatory cytokines, or changes in concen-
tration over time, are associated with progression of radiographic knee
osteoarthritis (OA) and patient-reported outcomes in subjects with
previous meniscectomy.
Methods: We studied 132 subjects at two time points after menis-
cectomy. At ﬁrst examination they were mean (range) 52 (32-73) years
old and had been meniscectomized 18 (15-22) years earlier, with asecond examination 7.5 (4-10) years later (Fig. 1A). We obtained
synovial ﬂuid, patient-reported outcomes, semiﬂexed weightbearing
tibiofemoral and skyline patellofemoral radiographs at both exami-
nations; 71 subjects had synovial ﬂuid available from both examina-
tions. We measured synovial ﬂuid concentrations of interleukin (IL)-6,
IL-8 and tumor necrosis factor (TNF)-a by a multiplex immunoassay
(Meso Scale Discovery). Radiographs were read according to the OARSIisons of cytokine levels at ﬁrst and second examinations.
